Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Patrick Freeman
Institution:
Prostate Cancer Clinical Trials Consortium
Observed institution:
Prostate Cancer Clinical Trials Consortium
ORCID:
0009-0004-3827-5269
Observed ORCID:
0009-0004-3827-5269
OpenAlex ID:
A5120850995
Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized germline genetic registry
2026
·
Channing J. Paller
, Ken Freitas
, et al.
·
Contemporary Clinical Trials Communications
Initial findings from the PROMISE Registry, a US decentralized, prospective prostate cancer genetic registry.
2026
·
Heather H. Cheng
, Justin Lorentz
, et al.
·
Journal of Clinical Oncology
Real-world cost effectiveness of androgen receptor pathway inhibitors for metastatic hormone sensitive prostate cancer: An economic evaluation utilizing data from the International Registry for Men with Advanced Prostate Cancer (IRONMAN).
2026
·
Rebecca Green
, Jake Vinson
, et al.
·
Journal of Clinical Oncology
P20 The Frequency of Mentions and Impact of Patient Input in HTA Decision Making in Cell and Gene Therapies Across the UK, Canada, and Australia
2025
·
Iro Malekou
, Sebastien Sanseau
, et al.
·
Value in Health
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type